Evaluate PKs and Efficacy Assessment of Palifermin in Patients With Sarcoma

NCT00267046 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma
Oral Mucositis

Interventions

DRUG: Palifermin
DRUG: Placebo
DRUG: Adriamycin (Doxorubicin)
DRUG: Ifosfamide
DRUG: Vincristine
DRUG: Cisplatin

Sponsor

M.D. Anderson Cancer Center